Buphenyl Therapy for Byler's Disease
Compassionate Use of Buphenyl® in the Treatment of Byler's Disease
Sponsor: University of Pittsburgh
This observational or N/A phase trial investigates Byler Disease and is currently ongoing. University of Pittsburgh leads this study, which shows 6 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Apr 2018 — Jan 2021 [monthly]
No Longer Available
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
No Longer Available NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
No Longer Available NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.